PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,535 | -7.8% | 145 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | +20.0% | 145 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $5,000 | -16.7% | 145 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | +20.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -16.7% | 145 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | -14.3% | 145 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $7,000 | -22.2% | 145 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | +28.6% | 145 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,000 | 0.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 145 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $6,000 | -14.3% | 145 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $7,000 | +40.0% | 145 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $5,000 | -28.6% | 145 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $7,000 | +40.0% | 145 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $5,000 | 0.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |